Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Zevra Therapeutics (ZVRA) Current Assets (2016 - 2025)

Historic Current Assets for Zevra Therapeutics (ZVRA) over the last 11 years, with Q3 2025 value amounting to $225.1 million.

  • Zevra Therapeutics' Current Assets rose 12637.82% to $225.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was $225.1 million, marking a year-over-year increase of 12637.82%. This contributed to the annual value of $86.0 million for FY2024, which is 104.79% down from last year.
  • Latest data reveals that Zevra Therapeutics reported Current Assets of $225.1 million as of Q3 2025, which was up 12637.82% from $226.3 million recorded in Q2 2025.
  • In the past 5 years, Zevra Therapeutics' Current Assets ranged from a high of $226.3 million in Q2 2025 and a low of $60.9 million during Q2 2024
  • For the 5-year period, Zevra Therapeutics' Current Assets averaged around $111.5 million, with its median value being $99.4 million (2024).
  • Per our database at Business Quant, Zevra Therapeutics' Current Assets skyrocketed by 155311.89% in 2021 and then plummeted by 4112.66% in 2024.
  • Quarter analysis of 5 years shows Zevra Therapeutics' Current Assets stood at $115.1 million in 2021, then fell by 19.31% to $92.8 million in 2022, then decreased by 6.35% to $86.9 million in 2023, then fell by 1.05% to $86.0 million in 2024, then surged by 161.68% to $225.1 million in 2025.
  • Its Current Assets was $225.1 million in Q3 2025, compared to $226.3 million in Q2 2025 and $81.6 million in Q1 2025.